Schulman-Galambos C, Galambos R
Arch Otolaryngol. 1979 Feb;105(2):86-90. doi: 10.1001/archotol.1979.00790140032006.
Brain stem evoked response audiometry (BERA) has been used as an auditory screening procedure in three groups of newborn infants. Group 1 consisted of 220 normal-term infants who were tested within 72 hours of birth; no hearing abnormalities were uncovered (386 ears), and their threshold responses (for clicks) lay between a 10- and 20-dB hearing level (re: adult). Group 2 consisted of 75 newborns who were treated in an intensive care unit for one to 14 weeks; four were found to have severe sensorineural hearing loss (seven ears) at the time of discharge. Group 3 consisted of a group of 325 infants, 1 year or older, who had previously been discharged from the same intensive care unit; of these infants, an additional four showed severe sensorineural hearing loss. All abnormalities that were identified by BERA were subsequently confirmed by conventional audiometric measures. The estimate of an incidence of severe hearing loss in one of 50 infants who required intensive care in the neonatal period calls for careful testing of this population.
脑干听觉诱发电位听力测定（BERA）已被用作三组新生儿的听力筛查程序。第一组由220名足月儿组成，他们在出生后72小时内接受了测试；未发现听力异常（386只耳朵），其阈值反应（针对咔嗒声）在10至20分贝听力水平之间（相对于成人）。第二组由75名在重症监护病房接受一至十四周治疗的新生儿组成；出院时发现其中四名患有严重的感音神经性听力损失（七只耳朵）。第三组由一组325名一岁或以上的婴儿组成，他们之前已从同一重症监护病房出院；在这些婴儿中，又有四名出现严重的感音神经性听力损失。所有通过BERA识别出的异常随后均通过传统听力测定方法得到证实。对于在新生儿期需要重症监护的每50名婴儿中就有一名出现严重听力损失的估计，需要对这一人群进行仔细测试。
